Lilly presents obesity drug trial results at ObesityWeek 2026
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
People who feel humiliated tend to be less happy, and rumination may partly explain why
Humiliation can leave memories that are hard to shake. A new study suggests that people who have felt humiliated tend to be less happy, and that repetitive negative thinking may be part of the reason.
NHS England on track to miss key cancer treatment target by 10,000 patients
Exclusive: 2,850 more patients a month would need to be treated within 62 days to meet March 2027 goal, as experts warn of failure of leadership Nearly 10,000 more cancer patients in England will not be treated on time because the government will fail to meet its targets, amid a failure of leadership, focus and resource, experts have…
New biomarkers for Alzheimer's disease, depression and beyond
Newly developed biomarkers may enhance clinicians' ability to detect and treat disorders of the nervous system, including Alzheimer's disease, mood disorders and neurodevelopmental conditions.
Packers RB Josh Jacobs had surgery to fix finger on Friday
Packers running back Josh Jacobs had surgery on his broken finger on Friday. He is expected to miss 2-3 weeks.
- Packers RB Josh Jacobs had surgery on Friday for broken right ring finger.
- He is projected to return in coming weeks but miss Sunday's Vikings game.
- Packers will decide by Saturday if Jacobs goes on injured reserve.
New investigational drug delivers up to 23.3% weight loss in people with obesity and diabetes
New data from a phase 2b study being presented at the 2026 annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct.
Eli Lilly Stock Barely Moved Following Viking Therapeutics' Impressive Clinical Results. Here's Why.
Both stocks may be worth considering for those looking to capitalize on the anti-obesity market.